Upregulation of microRNA-1 and microRNA-133 contributes to arsenic-induced cardiac electrical remodeling

International Journal of Cardiology

Volumn 167, Issue 6, 2013, Pages 2798-2805

  Shan, Hongli ^a   Zhang, Yong ^a   Cai, Benzhi ^a   Chen, Xi ^a   Fan, Yuhua ^a   Yang, Lili ^a   Chen, Xichuang ^a   Liang, Haihai ^a   Zhang, Ying ^a   Song, Xiaohui ^a   Xu, Chaoqian ^a   Lu, Yanjie ^a   Yang, Baofeng ^a   Du, Zhimin ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Arsenic trioxide; microRNA; Potassium channels; QT interval; SRF

Indexed keywords

ARSENIC TRIOXIDE; DELAYED RECTIFIER POTASSIUM CHANNEL; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR2.1; MICRORNA; MICRORNA 1; MICRORNA 133; POTASSIUM CHANNEL HERG; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOTOXICITY; CELL ISOLATION; CONTROLLED STUDY; DEPRESSION; DOWN REGULATION; GENE; GENE REPRESSION; GUINEA PIG; HEART REPOLARIZATION; HEART VENTRICLE REMODELING; KCNH2 GENE; KCNJ2 GENE; MALE; MORTALITY; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; QRS COMPLEX; QT INTERVAL; QT PROLONGATION; REAL TIME POLYMERASE CHAIN REACTION; SUDDEN CARDIAC DEATH; TORSADE DES POINTES; UPREGULATION; WESTERN BLOTTING;

ARSENIC TRIOXIDE; MICRORNA; POTASSIUM CHANNELS; QT INTERVAL; SRF;

ANIMALS; ARSENICALS; ATRIAL REMODELING; CELLS, CULTURED; GUINEA PIGS; LONG QT SYNDROME; MALE; MICRORNAS; MYOCYTES, CARDIAC; OXIDES; UP-REGULATION;

EID: 84883775625     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.07.009     Document Type: Article

References (37)

1. H.D. Sun, L. Ma, X.C. Hu, and T.D. Zhang Ai-Ling I treated 32 cases of acute promyelocytic leukemia Chin J Integr Chin West Med 12 1992 170 171
2. D. Cyranoski Arsenic patent keeps drug for rare cancer out of reach of many Nat Med 13 2007 1005
3. E. Fox, B.I. Razzouk, and B.C. Widemann Phase 1 trial and pharmacokinetic study of arsenic trioxide in children and adolescents with refractory or relapsed acute leukemia, including acute promyelocytic leukemia or lymphoma Blood 111 2008 566 573
4. C. Niu, H. Yan, and T. Yu Studies on treatment of acute promyelocytic leukemia with arsenic trioxide: remission induction, follow-up, and molecular monitoring in 11 newly diagnosed and 47 relapsed acute promyelocytic leukemia patients Blood 94 1999 3315 3324
5. J. Zhou, Y. Zhang, and J. Li Single-agent arsenic trioxide in the treatment of children with newly diagnosed acute promyelocytic leukemia Blood 115 2010 1697 1702
6. D. Unnikrishnan, J.P. Dutcher, and N. Varshneya Torsades de pointes in 3 patients with leukemia treated with arsenic trioxide Blood 97 2001 1514 1516
7. K. Ohnishi, H. Yoshida, and K. Shigeno Prolongation of the QT interval and ventricular tachycardia in patients treated with arsenic trioxide for acute promyelocytic leukemia Ann Intern Med 133 2000 881 885
8. H.L. Sun, W.F. Chu, and D.L. Dong Choline-modulated arsenic trioxide-induced prolongation of cardiac repolarization in guinea pig Basic Clin Pharmacol Toxicol 98 2006 381 388
9. A. Dennis, L. Wang, X. Wan, and E. Ficker hERG channel trafficking: novel targets in drug-induced long QT syndrome Biochem Soc Trans 35 2007 1060 1063
10. E. Ficker, Y.A. Kuryshev, and A.T. Dennis Mechanisms of arsenic-induced prolongation of cardiac repolarization Mol Pharmacol 66 2004 33 44
11. A.A. Domenighetti, C. Boixel, D. Cefai, H. Abriel, and T. Pedrazzini Chronic angiotensin II stimulation in the heart produces an acquired long QT syndrome associated with IK1 potassium current downregulation J Mol Cell Cardiol 42 2007 63 70
12. N. Gaur, Y. Rudy, and L. Hool Contributions of ion channel currents to ventricular action potential changes and induction of early afterdepolarizations during acute hypoxia Circ Res 105 2009 1196 1203
13. B.P. Lewis, I.H. Shih, M.W. Jones-Rhoades, D.P. Bartel, and C.B. Burge Prediction of mammalian microRNA targets Cell 115 2003 787 798
14. V. Ambros The functions of animal microRNAs Nature 431 2004 350 355
15. Y. Zhao, E. Samal, and D. Srivastava Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis Nature 436 2005 214 220
16. J.F. Chen, E.M. Mandel, and J.M. Thomson The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation Nat Genet 38 2006 228 233
17. R.J. Diaz, C. Zobel, and H.C. Cho Selective inhibition of inward rectifier K + channels (Kir2.1 or Kir2.2) abolishes protection by ischemic preconditioning in rabbit ventricular cardiomyocytes Circ Res 95 2004 325 332
18. B. Yang, H. Lin, and J. Xiao The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2 Nat Med 13 2007 486 491
19. J. Ai, R. Zhang, and Y. Li Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction Biochem Biophys Res Commun 391 2010 73 77
20. X. Luo, H. Zhang, J. Xiao, and Z. Wang Regulation of human cardiac ion channel genes by microRNAs: theoretical perspective and pathophysiological implications Cell Physiol Biochem 25 2010 571 586
21. H. Shan, Y. Zhang, and Y. Lu Downregulation of miR-133 and miR-590 contributes to nicotine-induced atrial remodelling in canines Cardiovasc Res 83 2009 465 472
22. Y. Lu, Y. Zhang, and H. Shan MicroRNA-1 downregulation by propranolol in a rat model of myocardial infarction: a new mechanism for ischaemic cardioprotection Cardiovasc Res 84 2009 434 441
23. C.E. Chiang, H.N. Luk, T.M. Wang, and P.Y. Ding Prolongation of cardiac repolarization by arsenic trioxide Blood 100 2002 2249 2252
24. E. Hayes, M.K. Pugsley, W.P. Penz, G. Adaikan, and M.J. Walker Relationship between QaT and RR intervals in rats, guinea pigs, rabbits, and primates J Pharmacol Toxicol Methods 32 1994 201 207
25. D.L. Dong, C. Chen, and R. Huo Reciprocal repression between microRNA-133 and calcineurin regulates cardiac hypertrophy: a novel mechanism for progressive cardiac hypertrophy Hypertension 55 2010 946 952
26. + channel blockade by the novel antiviral drug sophocarpine Biol Pharm Bull 31 2008 627 632
27. Kr potassium channel Cell 81 1995 299 307
28. E.T. Yeh, and C.L. Bickford Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management J Am Coll Cardiol 53 2009 2231 2247
29. B. Drolet, C. Simard, and D.M. Roden Unusual effects of a QT-prolonging drug, arsenic trioxide, on cardiac potassium currents Circulation 109 2004 26 29
30. X. Zhao, T. Feng, and H. Chen Arsenic trioxide-induced apoptosis in H9c2 cardiomyocytes: implications in cardiotoxicity Basic Clin Pharmacol Toxicol 102 2008 419 425
31. + currents densities in ventricular myocytes of guinea pigs by chronic oxidant stress Acta Pharmacol Sin 25 2004 751 755
32. D.L. Dong, Z. Li, H.Z. Wang, Z.M. Du, W.H. Song, and B.F. Yang Acidification alters antiarrhythmic drug blockade of the ether-a-go-go-related gene (HERG) channels Basic Clin Pharmacol Toxicol 94 2004 209 212
33. B.F. Yang, D.H. Xu, and C.Q. Xu Inactivation gating determines drug potency: a common mechanism for drug blockade of HERG channels Acta Pharmacol Sin 25 2004 554 560
34. + channel in human cardiac myocytes. Alterations in channel behavior in myocytes isolated from patients with idiopathic dilated cardiomyopathy Circulation 92 1995 164 174
35. Z. Wang, B. Fermini, and S. Nattel Rapid and slow components of delayed rectifier current in human atrial myocytes Cardiovasc Res 28 1994 1540 1546
36. Z. Lu, K. Kamiya, T. Opthof, K. Yasui, and I. Kodama Density and kinetics of I(Kr) and I(Ks) in guinea pig and rabbit ventricular myocytes explain different efficacy of I(Ks) blockade at high heart rate in guinea pig and rabbit: implications for arrhythmogenesis in humans Circulation 104 2001 951 956
37. X. Chen, H. Shan, and J. Zhao L-type calcium current (ICa, L) and inward rectifier potassium current (IK1) are involved in QT prolongation induced by arsenic trioxide in rat Cell Physiol Biochem 26 2010 967 974